Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEpe Special Opp Regulatory News (ESO)

Share Price Information for Epe Special Opp (ESO)

Share Price is delayed by 15 minutes
Get Live Data
235.00    0.00 (0.00%)
Bid:
232.00
Ask:
238.00
Spread: 6.00 (2.586%)
Market Cap: £57.27m
ESO Live PriceLast checked at - London Stock Exchange

Intraday Epe Special Opp Share Chart

Director/PDMR Shareholding

15 Nov 2018 07:00

RNS Number : 4041H
EPE Special Opportunities Limited
15 November 2018
 

EPE Special Opportunities Limited

 

Director / PDMR Shareholding

 

EPE Special Opportunities Limited ("ESO" or the "Company"), announces that it has been notified of the following transaction.

 

On 9 November 2018, Robert Quayle, being a Director of the Company and PDMR, purchased Ordinary Shares in the Company. Details of the Ordinary Shares purchased by the PDMR are provided below:

 

PDMR

Role

Number of Ordinary Shares Purchased

Price per Ordinary Share

Number of Ordinary Shares Held Following Purchase

Percentage of Total Voting Rights held Following Purchase

Robert Quayle

Company Director

12,500

180.00p

107,201

0.4%

 

The notification of dealing forms for each PDMR can be found below. This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

The person responsible for releasing this information on behalf of the Company is Hilary Jones of R&H Fund Services (Jersey) Limited.

 

Enquiries:

 

EPIC Private Equity LLP

+44 (0) 207 269 8865

Alex Leslie

R&H Fund Services (Jersey) Limited

+44 (0) 1534 825 323

Hilary Jones

Cardew Group Limited

+44 (0) 207 930 0777

Richard Spiegelberg

Numis Securities Limited

+44 (0) 207 260 1000

Nominated Advisor:

Stuart Skinner / Hugh Jonathan

Corporate Broker:

Charles Farquhar

 

DEALING NOTIFICATION FORM

FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Robert Quayle

2.

Reason for the notification

a)

Position/status

Company Director

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

EPE Special Opportunities Limited

b)

LEI

213800BQKN9C23A7LK98

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 Ordinary shares of 5p each.

 

 

ISIN: BMG3163K1053

 

b)

Acquisition of interest in shares

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

180.00 pence

12,500 Ordinary Shares

d)

Aggregated information:

Price 180.00 pence

Volume 12,500 Ordinary Shares

e)

Date of the transaction

9 November 2018

f)

Place of the transaction

London Stock Exchange; AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBIBDBSUBBGIS
Date   Source Headline
18th Jul 20247:00 amRNSAmendment and Extension of Unsecured Loan Notes
11th Jul 20247:00 amRNSNet Asset Value(s)
18th Jun 20247:00 amRNSNet Asset Value(s)
14th Jun 20245:00 pmRNSResult of AGM
16th May 20247:00 amRNSNotice of AGM
13th May 20247:00 amRNSNet Asset Value(s)
30th Apr 20247:00 amRNSDirector/PDMR Shareholding
16th Apr 20247:00 amRNSNet Asset Value(s)
9th Apr 20247:00 amRNSVesting - Share Matching Scheme/PDMR Shareholdings
9th Apr 20247:00 amRNSPosting of Report & Accounts
2nd Apr 20247:00 amRNSHolding(s) in Company
28th Mar 20247:00 amRNSAnnual Financial Report
5th Mar 20247:00 amRNSHolding(s) in Company
13th Feb 20246:00 pmRNSDirector/PDMR Shareholding
8th Feb 20244:45 pmRNSTrading Update
8th Feb 20247:00 amRNSInterest Payment on Unsecured Loan Notes
10th Jan 20247:00 amRNSNet Asset Value(s)
20th Dec 20237:00 amRNSHolding(s) in Company
20th Dec 20237:00 amRNSHolding(s) in Company
14th Dec 20237:00 amRNSNet Asset Value(s)
9th Nov 20237:00 amRNSNet Asset Value(s)
26th Oct 20236:29 pmRNSDirector/PDMR Shareholding
17th Oct 20236:30 pmRNSHolding(s) in Company
10th Oct 20234:30 pmRNSNet Asset Value(s)
3rd Oct 20236:00 pmRNSDirector Retirement
20th Sep 20237:00 amRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSHalf-year Report
4th Sep 20235:00 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSHolding(s) in Company
1st Aug 20237:00 amRNSInterest Payment on Unsecured Loan Notes
26th Jul 20237:00 amRNSUpdate on Share Buy Backs
24th Jul 20237:00 amRNSTransaction in Own Shares
24th Jul 20237:00 amRNSExtension of Unsecured Loan Notes
21st Jul 20237:00 amRNSTransaction in Own Shares
19th Jul 20239:30 amRNSAnnouncement of ZDP Share Buybacks
18th Jul 202310:00 amRNSPortfolio Update
11th Jul 20237:00 amRNSNet Asset Value(s)
30th Jun 20237:01 amRNSProposed Extension of Unsecured Loan Notes
30th Jun 20237:00 amRNSResult of AGM
12th Jun 20237:00 amRNSNet Asset Value(s)
19th May 20237:00 amRNSNotice of AGM
17th May 20237:00 amRNSPosting of Annual Report and Accounts
12th May 20237:00 amRNSHolding(s) in Company
12th May 20237:00 amRNSVesting - Share Matching Scheme/PDMR Shareholdings
12th May 20237:00 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSNet Asset Value(s)
20th Apr 20237:00 amRNSHolding(s) in Company
18th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20237:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.